Clinical trial Essays & Research Papers

Best Clinical trial Essays

  • clinical trial - 6927 Words
    Phase 1: Test a new drug or treatment to a small group of people (20-80) to evaluate its safety.Phase 2: The experimental drug or treatment is given to a large group of people (100-300) to see that the drug is effective or not for that treatment.Phase 3: The experimental drug or treatment is given to a large group of people (1000-3000) to see its effectiveness, monitor side effects and compare it to commonly used treatments.Phase 4: The 4 phase study includes the post marketing studies...
    6,927 Words | 22 Pages
  • Clinical Trials - 535 Words
    Clinical Trials ‘All patients should receive the best possible therapy AND the well-being of the individual research subject must take precedence over all other interests.’ Says article 11.3 of the ‘Declaration of Helsinki’, the Holy Grail for biomedical research on humans. With more and more clinical trials being conducted in developing countries, the question naturally arises…while outsourcing these trials, are the pharmaceutical companies growing to disregard this declaration? To be...
    535 Words | 2 Pages
  • Clinical Trial - 1490 Words
    Background Phase I trials classically represent first-in-human studies with the primary goals of : describing drug toxicities, describing the pharmacology of the drug (pharmacokinetics and sometimes pharmacodynamics) identifying an appropriate dose for phase II studies. With cytotoxic agents, an assumption has always been made that the higher the dose, the greater the likelihood of drug efficacy. This assumption was based on the log-cell kill...
    1,490 Words | 5 Pages
  • Clinical Trials Review - 3442 Words
    Solving the Drug Pipeline Problem through Improving the Clinical Trial Process c Abstract Each year fewer drugs are being approved by the FDA, yet the pharmaceutical industry is spending astronomical amounts developing new compounds. Modifications in the clinical trial process are needed in order to encourage the development of new possible therapeutics and bring new drugs onto the market. Reviewing the necessity of animal modeling, the institution of phase 0 and adaptive trial designs,...
    3,442 Words | 9 Pages
  • All Clinical trial Essays

  • Clinical Trial and Joint Venture
    GENZYME/GELTEX PHARMACEUTICALS JOINT VENTURE In early 1997, Greg Phelps, EVP of Genzyme Corporation, met with members of a joint- venture negotiating team to develop proposed terms of a joint-venture agreement. The venture would combine capabilities of Genzyme and GelTex Pharmaceuticals to market GelTex’s first product, RenaGel. GelTex was an early-stage biotech research company with two products in its pipeline. GelTex had neither the capital nor the marketing organization to...
    5,009 Words | 20 Pages
  • Clinical Trial and Phase - 1571 Words
    Executive Summary Case Background Merck & Co. is a global pharmaceutical company which is into drug research and production. Merck also markets its drugs on its own. It has launched several new products like Vioxx, Fosmax, Singulair etc for treating various diseases like osteoarthritis, asthma, osteoporosis etc. The company earned $5.9 billion on 1999 sales of $32.7 billion. This is a growth of 20% from 1998. LAB Pharmaceuticals is one such firm which is offering to license its drug...
    1,571 Words | 8 Pages
  • Clinical Trial and Vertex - 1629 Words
    Vertex Case Analysis Industry Challenges Vertex faced a very difficult decision when the company had to decide which drug candidates they should fund on their own, and which ones they should partner up with cooperate alliances who can financial support the projects. The company had revenue from various corporate partnerships and roughly $600 million in cash and short-term investments, but the company would not be able to fund more that two of its fours primary development projects. The...
    1,629 Words | 6 Pages
  • Heuristics: Clinical Trial and Product
    Persuasive Heuristics Lead to Successful Business Heuristics is known as methods or strategies used in the commercial industry in attracting consumer’s attention in order to achieve successful business transactions. These significant techniques are vastly seen in daily newspapers, magazines and media channels. Most advertisements portray colourful, attractive background carrying intuitive messages with the intention of captivating potential buyers. Heuristics mainly influences the...
    1,732 Words | 5 Pages
  • Clinical Trial Monitoring - 1511 Words
    CLINICAL TRIAL MONITORING- A GRADUAL PROCESS BY OGUNDOKUN OLUSEGUN. PGD (Clin. Res. (Can.)), BMLS (Nig,) MGHT, M-ASLM, MACRP. So you’re new to monitoring clinical research trials? Well, welcome. You’re probably starting out with little formal training, some knowledge of relevant FDA regulations, and a sense that the rules are just the tip of the iceberg. In addition, it’s likely that you aren’t certain what questions you should even ask about clinical trial monitoring. You are, however, not...
    1,511 Words | 4 Pages
  • Novo Nordisk Clinical Trials
    New Medication :Clinical Trials Phase I II III IV Requirements Testing an experimental drug or treatment in a, small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects The experimental study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety The experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its...
    707 Words | 6 Pages
  • Role of laboratory in Clinical Trials
     Role of Laboratory in Clinical Trials Laboratory data forms the backbone of all the clinical trials. Hence it is important to have good laboratory support and interaction with the laboratory in all the clinical trials. Clinical trials typically include two kinds of activity a) evaluation and validation of new clinical laboratory testing systems or b) laboratory evaluation of patients subjected to new clinical products or protocols, particularly those related...
    1,213 Words | 4 Pages
  • Risk Assessment for the AsthmaDrug1 Clinical Trial
    Risk Assessment for the AsthmaDrug1 Clinical Trial. Risk assessment is the process to identify areas of concern so an efficient response and an effective recovery plan can be placed if needed. In order to assess the potential risks a trial can face and to create a plan, six steps could be used: 1) Identify all the required Functions and Processes in the project; 2) Rank these identified functions and processes according to their “criticality”; 3) Determine the required time for recovery so...
    1,567 Words | 5 Pages
  • Clinical Trial and Nucleon Assignment Notes
    Nucleon Assignment Notes Porter’s 5 Forces Industry Analysis • Competition: Intense • Buyer Power: Moderate to High o Big pharma companies likely have a lot of power, although as a small firm, your power increases once you clear phases of drug trials. • Supplier Power: Unsure, Moderate? o The case makes it sound like there’s not many manufacturers out there for contracting purposes. Not sure what power suppliers of raw materials have. • Threat of Substitutes: Moderate to High o Lots...
    661 Words | 3 Pages
  • Clinical Trials from Paper to EDC
    Clinical Trials from Paper to EDC (Electronic Data Capture) Roll No 43 CLINICAL TRIALS FROM PAPER TO EDC (ELECTRONIC DATA CAPTURE) IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR MASTER OF FINANCIAL MANAGEMENT 2013-2014 ROLL NO. 43 JAMNALAL BAJAJ INSTITUTE OF MANAGEMENT STUDIES Jamnalal Bajaj Institute of Management Studies, Mumbai Page 1 Clinical Trials from Paper to EDC (Electronic Data Capture) Roll No 43 Acknowledgement A journey that started some three years...
    9,997 Words | 79 Pages
  • Issues of Clinical Trials in India by Vallinadh Karamcheti
    Clinical trials in INDIA- Legal issues By: Vallinadh Karamcheti Abstract: Clinical trials are conducted to ensure the safety and efficacy of the drug. They are conducted on the human subjects. Hence the clinical trials are liable to many legal aspects. Clinical trials are conducted in four phases. (Phase I, Phase II, Phase III, & Phase IV). All the phases of the clinical trials should comply with several legal aspects, as life of a person may be at risk if anything goes wrong with the clinical...
    2,567 Words | 8 Pages
  • A Multistep Recruitment Strategy to a Participant-Intensive Clinical Trial
    Available online at www.sciencedirect.com Applied Nursing Research 23 (2010) 227 – 232 www.elsevier.com/locate/apnr A multistep recruitment strategy to a participant-intensive clinical trial Kim Dupree Jones, PhD, RNCa,⁎, Ann C. Reiner, RN, MN, OCN®b a Oregon Health & Science University, Schools of Nursing and Medicine, Portland, OR 97239-2941, USA b Oregon Health & Science University, School of Nursing, Portland, OR, USA Received 25 June 2008; revised 28 August 2008; accepted 2...
    5,290 Words | 15 Pages
  • Global Clinical Trials Review For Addison’s Disease by 2014
    The Leading Distributor of Market Research Reports, marketoptimizer.org publishes report on “Addison’s Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2014”. Researcher’s clinical trial report, “Addison’s Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2014″ provides data on the Addison’s Disease (Primary or Chronic Adrenal Insufficiency) clinical trial scenario. This report provides elemental information and data...
    623 Words | 3 Pages
  • 2014 Vascular Dementias Therapeutics Clinical Trials Market
    MarketOptimizer.org adds report “Vascular Dementias Global Clinical Trials Review, H2, 2014” to its store. Vascular dementia or "multi-infarct dementia" is dementia caused by problems in the supply of blood to the brain, typically by a series of minor strokes. Vascular dementia is the second most common form of dementia after Alzheimer's disease (AD) in older adults. Multi-infarct dementia (MID) is thought to be irreversible and it is caused by a number of small strokes or sometimes a large...
    484 Words | 2 Pages
  • How Supply Chain Visibility Can Change the Face of Clinical Trials
    HOW SUPPLY CHAIN VISIBILITY CAN CHANGE THE FACE OF CLINICAL TRIALS October 2012 When it comes to clinical trials, many pharmaceutical companies seem to be lacking something. Opportunities to make financial and time saving benefits are not being taken. And yet easy to initiate solutions are now available that can affect genuine change. Often discussed but rarely seen in action, clinical trials supply chain visibility looks set to significantly improve the entire clinical trials process....
    2,799 Words | 9 Pages
  • Latest Reports: Coronary Vasospasm Global Clinical Trials Review, H2, 2014
    Coronary Vasospasm Global Clinical Trials Review, H2, 2014 Market Research Report clinical trial report, Coronary Vasospasm Global Clinical Trials Review, H2, 2014" provides data on the Coronary Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a...
    647 Words | 4 Pages
  • Clinical Governance - 1605 Words
    Explain what is meant by the term ‘clinical governance’ AND discuss the implications and impact of clinical governance on practicing pharmacists and pharmacy services. Throughout the world, societies are striving to determine how best to organise their health systems and deliver services. Increasingly, there is recognition that the development and evaluation of new therapies and diagnostic tools is only part of the answer to better health care(1). Clinical governance first began to appear in...
    1,605 Words | 6 Pages
  • Clinical Supervision - 2753 Words
    Clinical supervision sits at the heart of the UK Government's agenda for improving the quality of service delivery (Department of Health, 1997, 1998, 1999). The practice in the workplace was introduced as a way of using reflective practice and shared experiences as a part of continuing professional development. Clinical supervision has ensured that standards of clinical care remain a key mechanism for monitoring the performance of Trusts, with clinical performance measures being given equal...
    2,753 Words | 11 Pages
  • Clinical Audit - 719 Words
    CLINICAL AUDIT LITERATURE AND EVIDENCES [ARTICLE] Audit is currently defined as a cyclical activity incorporating both systematic evaluation of the quality of clinical practice and action .The aim of audit is to establish the extent to which actual clinical practice compares with best clinical practice. Bowie etal(2012 It incorporates the systematic and critical analysis by nurses, midwives and health visitors, in conjunction with other staff, of the planning, delivery and...
    719 Words | 2 Pages
  • Bio-Medical Ethics; a Paper on Ethical Issues Surrounding Conduct of Clinical Trials in Developing Countries
    Title Bio-medical Ethics; A paper on Ethical Issues Surrounding Conduct of Clinical Trials in Developing Countries By XXXXXXXXX October 2011 Table of Contents Bio-medical Ethics; A paper on Ethical Issues Surrounding Conduct of Clinical Trials in Developing Countries 1 1.0 Introduction 3 2.0 Scenario of current international guidelines 4 3.0 The case of HIV Vaccine trials with secondary end-points 7 4.0 Probable Solutions 10 5.0 Conclusion 12 6.0 Bibliography 12...
    3,068 Words | 9 Pages
  • Clinical Governance and Patient Safety
    HS711 CLINICAL GOVERNANCE AND PATIENT SAFETY Student no 1106154 UP:12/04/2012-07:22:52 WM:12/04/2012-07:23:40 M:HS711-4-SP A:11a1 R:1106154 C:247CF1EADC9DA0F26065022703A21C45C87E8E62 The aim of this assignment is to explore the clinical governance in connection with the provision of patient safety when administering drugs, study will relate to an incident in the author workplace (See appendix 1). The author presents the outcomes of Care Quality Commission (CQC 2010) related to this situation...
    4,013 Words | 15 Pages
  • GUIDELINE FOR GOOD CLINICAL PRACTICE
    INDEX 1.Introduction to Clinical Trials 3 2.Clinical Trial Protocol 5 3.International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use 6 1.1.Introduction to GCP 6 1.2.Sections of GCP Guidelines 6 3.2.1.1Section 1- Glossary of various terms 6 3.2.1.2Section 2- Principles of ICH-GCP 7 3.2.1.3Section 3- Institutional Review Board/Independent Ethics Committee(IRB/IEC) 8 3.2.1.4Responsibilities 8 3.2.1.5Composition, Functions and...
    7,016 Words | 27 Pages
  • Participants’ Responsibilities in Clinical Research
    Discussions of the ethics and regulation of clinical research have a great deal to say about the responsibilities of investigators, sponsors, research institutions, and institutional review boards, but very little about the responsibilities of research participants. In this article, we discuss the responsibilities of participants in clinical research. We argue that competent, adult participants are responsible for complying with study requirements and fulfilling other obligations they...
    340 Words | 2 Pages
  • Good Clinical Lab Practice
    Robarts Clinical Imaging Research Laboratories STANDARD OPERATING PROCEDURE FOR SPECIMEN HANDLING SOP Number: GCP PM 306.02 Version Number & Date: 2nd version; 17June 2010 Effective Date: 05 July 2010 Superseded Version Number & Date (if applicable): 1st version; 24 October 2005 Review Date: 05 July 2012 Revision Chronology: Version Number Version Date Reason for Change 306.01 306.02 24 October 2005 17 June 2010 Initial Version Review and update; compliance with Lawson SOPs Printed...
    1,197 Words | 7 Pages
  • Clinical Information System - 6441 Words
    OUR JOURNEY TOWARDS THE IMPLEMENTATION OF A CLINICAL INFORMATION SYSTEM TO THE CRITICAL CARE ENVIRONMENT INTRODUCTION The delivery of health care has become increasingly complex, and most clinical research focuses on new approaches to diagnosis and treatment. There have been significant advances in medical technology used in patient treatment and care. The Intensive Care Unit (ICU) in an acute hospital is designed to treat the most complex and unstable medical and surgical patient....
    6,441 Words | 22 Pages
  • Reflection Clinical Incident Hiv
    ABTRACT Central Venous Catheter Blood stream infections (CVCBSIs) is a major cause of morbidity and mortality in patients with end- stage renal disease treated with chronic haemodialysis (Jaber 2005).The purpose of this review is to determine whether the use of Biopatch on the exit site of central venous catheter (CVC) can help prevent infection. Before any research was undertaken, a focused question was formulated and a search strategy was then developed to compare the available evidence....
    3,895 Words | 12 Pages
  • Clinical Research Past and Present
    Clinical Research Past and Present Tina Ross-Cruz Abstract Research disasters have been noted for years. In the early years, the reasons for these disasters was that there were no regulations governing the protection of human beings; and there were no guidelines for safety and efficacy of a new medication or treatment prior to the use in humans. Now regulations and guidelines are in effect for the protection of human subjects. These guidelines and regulations also protect the...
    6,946 Words | 19 Pages
  • Clinical nursing and nursing education
     Comparison of Methodological Quality and Study/Report Characteristics between Quantitative Clinical Nursing and Nursing Education Articles Why does funding have a lot to do with the comparisons of Quantitative Clinical Nursing and Nursing Education Articles? Nursing education research, an inclusive science in which both qualitative and quantitative approaches are used and accepted. Nursing education lacks common metrics and standardized approaches for...
    399 Words | 2 Pages
  • Randomized Controlled Trials - 1777 Words
    What is meant by double-blind, randomized controlled trial? Explain why such trials are used in psychological research with reference to one specific, published psychological experiment. Randomized controlled trials are considered the gold level standard of proof of many research techniques where treatments and therapies are concerned by the scientific community. A study in which participants are allocated at random to receive one of several treatments testing the effectiveness of...
    1,777 Words | 6 Pages
  • Directory of Clinical Research Companies in India
    Directory of Clinical Research Companies In India December 2005 4th & 5th Floors, Astral Heights, Road No. 1, Banjara Hills, Hyderabad-500034, India Tel: +91-40-23430203-07, Fax: +91-40-23430208, E-mail: info@cygnusindia.com Website: www.cygnusindia.com Disclaimer: All information contained in this report has been obtained from sources believed to be accurate by Cygnus Business Consulting & Research (Cygnus). While reasonable care has been taken in its preparation, Cygnus makes no...
    1,390 Words | 5 Pages
  • The Effects of Clinical Instructors on Nursing Students
    The Effects of Clinical Instructors on Nursing Students The effects of nurse instructors -- or preceptors, as they are called in the nursing field -- on nursing students in clinical settings can range from helpful to detrimental. Depending on the preceptor, the student may come away from the clinical teaching experience either confident or uncertain about herself as a nurse and her skills and may view nursing as either a positive or negative experience. Effective characteristics of clinical...
    385 Words | 2 Pages
  • Gracy Final Application Of Concept Analysis To Clinical Practice
     Application of Concept Analysis to Clinical Practice Gracy Zachariah Grand Canyon University: NUR-502 May 27, 2015 Application of Concept Analysis to Clinical Practice Concepts are terms for phenomena that can happen in nature or in thought. Concept analysis should have a purpose. A concept may be comparatively a summary and created with an aim. Walker and Avant’s (2011) concept analysis outline is used to measure the job satisfaction of...
    1,255 Words | 4 Pages
  • “A COMPARATIVE CLINICAL STUDY ON THE THERAPEUTIC EFFECT OF VAITARANA BASTI AND YOGARAJA GUGGULU IN AMAVATA W.S.R. TO RHEUMATOID ARTHRITIS”
     “A COMPARATIVE CLINICAL STUDY ON THE THERAPEUTIC EFFECT OF VAITARANA BASTI AND YOGARAJA GUGGULU IN AMAVATA W.S.R. TO RHEUMATOID ARTHRITIS” 5. TITLE OF THE TOPIC STUDY: “A COMPARATIVE CLINICAL STUDY ON THE THERAPEUTIC EFFECT OF VAITARANA BASTI AND YOGARAJA GUGGULU IN AMAVATA W. S. R. TO RHEUMATOID ARTHRITIS.” 6.BRIEF RESUME OF THE INTENDED WORK: 6.1. NEED FOR STUDY: Amavata is a disease of vitiated vata associated with ama and it persists with multiple systemic...
    1,495 Words | 6 Pages
  • Can a Slow Continuous Intravenous Therapy Prolong the Life of Peripheral Intravenous Cannulae in the Clinical Setting?
    Can a slow continuous intravenous therapy prolong the life of peripheral intravenous cannulae in the clinical setting? Introduction Background There is lack of current research evidence to suggest that continuous infusion also known as to ‘keep vein open’ to a peripheral intravenous cannula will prolong the life expectancy of a cannula. There is much discussion and debate among health care staff over the ability of a continuous infusion to prolong the life of a cannula. Many patients are...
    2,552 Words | 8 Pages
  • Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines
    OBJECTIVE: To recommend effective strategies for implementing clinical practice guidelines (CPGs). DATA SOURCES: The Research and Development Resource Base in Continuing Medical Education, maintained by the University of Toronto, was searched, as was MEDLINE from January 1990 to June 1996, inclusive, with the use of the MeSH heading "practice guidelines" and relevant text words. STUDY SELECTION: Studies of CPG implementation strategies and reviews of such studies were selected. Randomized...
    508 Words | 2 Pages
  • Quality of Life, Research Critique
    Running head: QUALITY OF LIFE, RESEARCH CRITIQUE Quality of Life, Research Critique Lisa Spann Grand Canyon University Introduction to Nursing Research NRS-433V Professor Anna Auler October 04, 2012 Quality of Life, Research Critique As the ability to prolong chronological life advances, the question is when is the effort enough or too much? The term coined “quality of life” or QoL is thrown out to be a point of reference. The certain point at which determined the efforts are no...
    847 Words | 3 Pages
  • Wage Payment Model for Human Guinea Pigs
    Wage Payment Model for Human Guinea Pigs What would you do if you were asked to get paid to spend the entire week lying down on a comfortable bed for human clinical trial? There will be medications to take and occasional checkups that might be disturbing, but considering the good pay, some might think it is worth the pain. Many of the research subjects, who are often called “guinea pigs,” participate in the human clinical research for the relatively easy money-making process. Since growing...
    1,549 Words | 5 Pages
  • health evaluation outcome - 2889 Words
    ST JOHN'S Final Paper 219 Health Outcome Assessment j.d 2013/12/11 1.Describe the importance of the use of HE outcomes in pharmaceutical promotion. Health economics is the study of how scarce resources are allocated among alternative uses for the care of sickness and the promotion, maintenance and improvement of health. It includes the study of how healthcare and health-related services, their costs and benefits, and health itself are distributed among individuals and groups in...
    2,889 Words | 8 Pages
  • Biocon India - 1338 Words
    Biocon Ltd. Building a Biotech Powerhouse Case analysis -Rajdeep Desai Introduction: Established in 1978, Biocon Limited is Asia’s premier biotechnology company and India's largest biotechnology company by revenue. It is the only Asian company among the top 25 in global biopharma. Biocon is called as Poster child of Biotech in India. The Group, promoted by Ms. Kiran Mazumdar Shaw, is a fully-integrated, innovation-driven healthcare enterprise with strategic focus on biopharmaceuticals and...
    1,338 Words | 6 Pages
  • Drug Journey - 2173 Words
    Drug Journey Thesis: The process of drugs in pharmaceuticals is actually a very long one. There are several different stages that a company undertakes in order to get their drug to the doctors, pharmacists and patients. We will look at this process over the next few minutes. Introduction: As a Chemistry major I’m passionate to study on drugs and would like to involve in pharmaceuticals. I’m also inspired from...
    2,173 Words | 6 Pages
  • Eli Lilly - 891 Words
    Heavyweight project team is a development project team consists of specialized experts that led by a project manager who has direct access to and responsibility for the work of all those involved in the project. There were five keys characteristics defined a heavyweight team at Lilly. • First, the teams were each given a very clear business charter “to focus exclusively on the development of a single compound.” • Second, each team was collocated and cross functional. • Third, the teams...
    891 Words | 3 Pages
  • practice case old pharma
    Practice case - OldPharma Client goal Our client is OldPharma, a major pharmaceutical company (pharmaco) with USD 10 billion a year in revenues. Its corporate headquarters and primary research and development (R&D) centers are in Germany, with regional sales offices worldwide. Description of OldPharma OldPharma has a long, successful tradition in researching, developing, and selling “small molecule” drugs. This class of drugs represents the vast majority of drugs today, including aspirin...
    2,056 Words | 7 Pages
  • Ebola - 1863 Words
    -에볼라 바이러스 취사율 Ebola virus is one of the four ebolaviruses known to cause disease in humans. It has the highest case-fatality rate of these ebolaviruses, averaging 83% since first described in 1976, although fatality rates up to 90% have been recorded in one epidemic (2002–03). There have also been more outbreaks of ebola virus than of any other ebolavirus. - 사망자 26 September 2014 – The United Nations World Health Organization (WHO) today said it is intensifying its cooperation with a wide...
    1,863 Words | 7 Pages
  • M3 Original Assignment - 691 Words
    M3 Original Assignment Are drug companies that test experimental drugs in foreign countries acting ethically? To answer this question, it is worth looking at why a drug company would experiment in a foreign country before even examining the negative impacts in doing so. Testing drugs internationally is done because it is cheaper and far easier to endanger trial patients in a foreign country. Now when exploring the reasons for the need to test at all, an act utilitarian may surmise that...
    691 Words | 2 Pages
  • European Industrial Pharmacists Group
    EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible Persons A. Introduction Maintaining competence throughout a career during which new and challenging professional responsibilities will be encountered is a fundamental ethical obligation for all those working in the pharmaceutical industry . This is particularly important for the...
    2,620 Words | 10 Pages
  • Abgenix Case Study - 1197 Words
    A. Introduction: Abgenix was a company founded in California who had a unique method for generating antibodies useful in treating a number of diseases, one of which was cancer. They named this unique method XenoMouse. Abgenix spent 7 years and $40 million to produce XenoMouse which was a genetically engineered mouse which could produce antibodies that would treat illnesses like cancer, transplant rejection and inflammation. B. Abgenix Ways To Generate Revenue: Abgenix generated...
    1,197 Words | 5 Pages
  • 1 Opening and Welcome Speech
    ADVANCED WORKSHOP : REVIEW OF DRUG DEVELOPMENT IN CLINICAL TRIALS BANGKOK, 2-6 FEB 2009 Opening and Welcome Speech Mrs Werawan Tangkeo The Deputy Secretary General of Thai Food and Drug Administration @ The Siam City Hotel, Bangkok 2-6 February 2009 Dr Viner, Dr Stevens, Dr Sato, and Dr Sudhichai, Distinguished participants, Ladies and Gentlemen: It gives me a great pleasure to welcome all of you and chair the Opening Ceremony this morning to the “Advanced Workshop: Review of Drug Development...
    624 Words | 3 Pages
  • Management Case Study - 1988 Words
    June 9-13, 2012 – Baltimore, Maryland 2012 ASHP Summer Meeting Management Case Study Submission and Format Guidelines Management Case Studies are 20-minute platform presentations followed by a 10-minute question and answer period. ASHP is seeking management case studies in specific topic areas: • Informatics • Leadership / Administration • Medication Safety • Clinical Conundrums This document will assist you in the preparation of your submission for a Management Case Study (MCS). The...
    1,988 Words | 7 Pages
  • cracking the whip at wyeth - 2040 Words
    Cracking The Whip At Wyeth - Businessweek Sign in with Facebook Email http://www.ibs.utm.my/myibs/courses/MRD20331_001/document... Or use your Businessweek account Password Forgot password Remember me Sign In Not registered? Sign up. Bloomberg Businessweek Magazine Cracking The Whip At Wyeth Posted on February 05, 2006 http://www.businessweek.com/stories/2006-02-05/cracking-the-whip-at-wyeth When Robert R. Ruffolo Jr. signed on at Wyeth (WYE ) in 2000, his mandate was...
    2,040 Words | 7 Pages
  • Research Paper - 1961 Words
    Clinical Trials and Research Today, most often people are unappreciative of the ‘simple things’ in life... Taking our family, friends, and luxuries for granted, unmindful of the fact they can be taken away at any time. Take disease for example, in some cases it may shock you and come out of nowhere. Whether or not its a fatal disease, or one that there is a cure for, a shocking illness can turn your whole world upside down. You almost feel as though there is nothing you can do anymore, your...
    1,961 Words | 5 Pages
  • inflation - 475 Words
    BFA726, Corporate Law and Regulation 25 Tutorial 9 – Week Commencing 23/09/2013 (Covers material from Chapters 19 & 20) Question 1 Should a company be allowed to pay a dividend to its shareholders even if the company's net assets fluctuate over time? Question 2 Spec Pty Ltd (Spec) is a property development company. It owns parcels of rural and semi-rural land in Victoria. Bill owns 80% of the shares in Spec and controls the composition of its board. Last year the company made a small...
    475 Words | 2 Pages
  • Ethics - 3580 Words
    CLINICAL ETHICS CLINICAL ETHICS Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry Paul A Komesaroff and Ian H Kerridge RELATIONSHIPS INVOLVING medical practitioners and the pharmaceutical industry raise serious concerns and The Medical Journal of the medical profession and the controversy within bothAustralia ISSN: 0025-729X 4 February 2002 176 2 118-121 broader community.1,2 Within the profession itself views differ sharply, from...
    3,580 Words | 12 Pages
  • PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022
    PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 On 01st FEB. 2014 Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of recombinant HBsAg vaccines has...
    832 Words | 7 Pages
  • Postcard - 413 Words
    16, January 2015 My Dearest, Classmates: I just got back from my virtual field trip to the National Institute of Nursing Research! I could go on and on about all the fun I had! The NINR takes pride in their mission to support and enhance the wellbeing of every individual in America through nursing research (National Institute of Nursing Research, 2011, para. 1). The most exciting bit of information that I found made this cardiac nurse’s heart flutter when the NINR included heart failure...
    413 Words | 2 Pages
  • star medicines - 279 Words
    Case for Seminars 2 and 3: Stephen is a board director of StarAlphaMedicines, a multinational pharmaceutical company headquartered in the UK. The company’s Research & Development department are working on a novel breast cancer drug. The drug could provide breakthrough treatment for millions of women in the company’s core markets in Europe and the US, and is likely to be a source of high revenue for StarAlphaMedicines, which has recently seen a fall in profits and a resulting drop in share...
    279 Words | 1 Page
  • Pharmaceutical Companies and Ethics - 919 Words
    Pharmaceutical Companies and Ethics It would be a mistake to claim that the pharmaceutical industry has not contributed to a better way of life and a better standard of living. They have come up with treatments for cancer-in some types of cancer they have even come up with the cure. It would also be naïve however to pretend that there are not some issues that have come up throughout the years that lead us to question whether the pharmaceutical industry’s main concern is the well being of the...
    919 Words | 3 Pages
  • overview of medical device registration in China
    Medical Device Regulatory Environment in China Non-confidential information Prepared for XXX 1 Agenda  Government Authorities  Classification of Medical Device  Registration of Imported Medical Device  Process, Timeline, and Dossiers Required  License Renewal and Re-registration  Modification of Medical Device License  Clinical Trial Requirements 2 Multiple government agencies are responsible for policy-making, monitoring and control of the medical device industry in China...
    1,691 Words | 31 Pages
  • Neonatal Abstinence Syndrome - 1038 Words
    Neonatal Abstinence Syndrome The purpose of this research critique is to inform the reader of a randomized clinical study regarding the treatment of Neonatal Abstinence Syndrome (NAS). This writer is interested in the treatment of drug exposed infants and the goals of reducing babies’ hospitalization in the Neonatal Intensive Care Unit (NICU). The study researches the adjunct therapy for treatment of NAS. The study will be broken down into the following units: protection of human participants,...
    1,038 Words | 3 Pages
  • Melanoma Therapeutics Market To 2020 - Rising Prevalence And Evolving Treatment Algorithms To Drive Market Growth
    leading business intelligence provider, has released its latest research report “Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth.” Melanoma is a highly heterogeneous disease comprising Cutaneous Melanoma (CM), Ocular Melanoma (OM), Mucosal Melanoma (MM), melanoma of the internal organs, and, according to some classifications, melanoma of the soft parts (non-bony and non-cartilaginous tissues) of the body. CM is by far the most...
    718 Words | 3 Pages
  • Abginemax - 2171 Words
     XenoMouse: Produces antibodies for disease targets  Benefits: Longer therapy, fewer side effects, faster drug development Abgenix & the Xenomouse 1 Case Questions • Which of the three alternatives would you recommend to the company? 1. A Pharmacol “hand-off” deal (who is Pharmacol)? 2. A Biopart “hand-in” deal (who is Biopart)? 3. “Go-it-alone” through Phase II & then decide a development strategy? • What are the direct financial implications of your answer? • What are the...
    2,171 Words | 17 Pages
  • EHR Material - 680 Words
    Unit 05 Assignment - Applying Information Technology Grading system: CCC Write a 1-2 page paper describing how information technology can be designed to assist with nursing hand-off. Attach it to this assignment as a Word document (.doc) or rich text format file (.rtf). Hand-offs occurs when patient care is transferred from one provider to another provider. It is important that the information about patient care is timely and accurate. In clinical settings, hand-offs have had some...
    680 Words | 3 Pages
  • Psy 285 Week 1 Assignment
    Experimental Research Elements PSY/285 August 6, 2012 Experimental Research Elements In the United States the development of a new drug, for human consumption is a long and difficult process requiring many levels of testing. Mandated by the food and drug administration (FDA) the rigorous process of new drug development can consists of at least four phases. If the FDA approves the new drug to be safe and effective for humans, generally, from start to finish the entire process of new drug...
    755 Words | 3 Pages
  • Ethics and the Pharmaceutical Industry - 3200 Words
    1. Introduction Over the past couple of decades, a sudden change has started to take over the way business is done. The time when no rules applied, and anyone could do what they pleased at the cost of others or the environment is rapidly ending. Instead, companies today have become aware that it is essential for them to employ ethics and morality in their actions, if not they will be heavily scrutinized and rejected by the public. This way of thinking also applies to the pharmaceutical...
    3,200 Words | 10 Pages
  • Research Article Critique on Alzheimer's Disease
    Danisha Stewart April 18, 2012 Research Article Critique 1 NURS 4922 1. Brodaty, H., Ames, D., Snowdon, J., Woodward, M., Kirwan, J., Clarnette, R., & ... Greenspan, D. (2005). Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial. International Journal of Geriatric Psychiatry, 20(12), 1153-1157. 2. The purpose of this study is to evaluate the efficacy and safety of low dose risperidone in treating psychosis of...
    1,720 Words | 7 Pages
  • Cialis Case - 9157 Words
    HARVARD BUSINESS SCHOOL 9-505-038 REV: JUl Y 2 8. 201 0 ElIE OFEK Product Team Cialis: Getting Ready to Market It was early 2002, and Mark Barbato, the executive director and global product team leader for Cialis, knew he faced a daunting task: launching a medicine for the treatment of male impotence in a market with an established leader-Viagra. 1 Not only had Viagra been generating over $1 billion in sales annually for its parent company Pfizer for three consecutive years,...
    9,157 Words | 36 Pages
  • Business Research Ethics - 630 Words
     Business Research Ethics Tasha Hughey RES/351 January 12, 2015 Mr. Grunig Business Research Ethics Business ethics is the principles and standards that determine acceptable conduct in business organizations. Unethical business research at work ranges from minor acts of deviance to immoral decisions that result in convictions of employees and company downfalls. Even though ethics is sometimes under looked in business it is an important conduct in the organization for a variety of reasons....
    630 Words | 2 Pages
  • Nicolas - 310 Words
    Nicolas Demery Group B To: Mark James (BioCell CEO) From: Nicolas Demery Date:05/13/13 Re: Contract Mark, I’m writing to you this morning regarding our contract with Nippon BigPharma. There is now three years ago that Nippon Big Pharma purchased our IMMUVAX product and the pivotal phase 3 human clinical trials are still not enrolled. According to our last report the process is only half completed. The main issue for us is that the revenue we expected is going to be significantly delayed....
    310 Words | 2 Pages
  • Investigational New Drug Review Process
    INVESTIGATIONAL NEW DRUG REVIEW PROCESS Investigational New Drug Review Process Prashanth Kumar Ponugoti Northeastern University INVESTIGATIONAL NEW DRUG REVIEW PROCESS Abstract Investigational New Drug (IND) review process begins from the time the sponsor files investigation new drug application and the purpose of the review is to confirm the safety and efficacy of the patient for the drug. Moreover in the process of review if the review committee notifies any deficiencies by the...
    1,524 Words | 6 Pages
  • Respiratory Therapy - 1288 Words
    Future of Respiratory Therapy By entering the field of respiratory therapy, one is entering a growing field of opportunity. There are continually emergent job opportunities in this field whereas there is also a rise of growth in the technology and developments in the field such as medicines, techniques, and other aspects. Respiratory therapy refers to both a subject area within clinical medicine and to a distinct health care profession. During the 20th century, there were many health care...
    1,288 Words | 4 Pages
  • Research Definition of Terms - 5405 Words
    DEFINITIONS OF COMMON RESEARCH-RELATED TERMS Abuse-liable: Pharmacological substances that have the potential for creating abusive dependency. Abuse-liable substances can include both illicit drugs (e.g., heroine) and licit drugs (e.g. methamphetamines). Adverse Effect: An undesirable and unintended, although not necessarily unexpected, result of therapy or other intervention. Anonymity: Anonymity exists when there are no identifiers on project materials that could link the data with individual...
    5,405 Words | 16 Pages
  • slngfsngj - 568 Words
    ould Animals Be Used for Scientific or Commercial Testing? Animal welfare charities reacted angrily to news in July that the number of animal experiments rose to a record high in Britain last year – a 40 per cent rise over the last decade. Two years ago, Cardiff University defended sewing kittens’ eyes shut, as means to find a cure for lazy eyes. In their statement, they said the purpose of the work and its conduct was approved by both the university’s own ethical review process and the Home...
    568 Words | 2 Pages
  • job description analysis - 1259 Words
    Review on Clinical Safety Specialist Job Analysis   Review job Analysis of the job description proper contents or lack there of: Identifying Top essential function of the job, determine the appropriateness of these function, identify the function that is missing or incomplete, educational level, certificates etc. Safety or other aspect deem important to do this job Human resource professionals use job descriptions and job analyses as basic building blocks for many human...
    1,259 Words | 5 Pages
  • Questions 6 - 535 Words
    Study Questions 6 1. What is the role of the pharmaceutical industry in the health care system? The pharmaceutical industry plays a pivotal role in the health care system. Without the pharmaceutical industry, health care would not evolve into what it is today. The reason why it plays such an important role in health care is because it helps address challenges associated with modern day diseases and illnesses. It controls prevent, treat, and cure many types of diseases. In support, according...
    535 Words | 2 Pages
  • Gene Therapy Drug Industry across World- Market Landscape & Emerging Trends
    Order By 31-Mar-2014 & Get 20% Discount "Gene Therapy Drug Pipeline Analysis" by Researcher gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country...
    405 Words | 3 Pages
  • Antegren Case Study - 8274 Words
    9-408-025 NOVEMBER 14, 2007 JOSHUA MARGOLIS THOMAS DELONG TERRY HEYMANN Antegren: A Beacon of Hope As Jim Mullen, CEO of Biogen Idec, drove into work on February 19, 2004, he considered both the tremendous hope and stiff challenge generated by the company the previous day. The company had announced its intention to submit an application to the U.S. Food and Drug Administration (FDA) seeking approval for Antegren, a drug that Biogen Idec was developing in partnership with Elan to treat multiple...
    8,274 Words | 33 Pages
  • Ich Gcp Guidelines - 19170 Words
    INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R1) Current Step 4 version dated 10 June 1996 (including the Post Step 4 corrections) This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process...
    19,170 Words | 72 Pages
  • Informed Consent - 2404 Words
    Mark A. Puno Instructor: Craig Bartholomaus English 102 27 March 2013 Informed Consent What is an informed consent? What do we know about it? Where did it come from? What purpose does it serves? These days, there is a variance in what informed consent means. Its definition depends on what specific manner it accentuates in accordance with the pertinent setting of application. The American Medical Association (AMA) has definitions on a clinical setting and on the field...
    2,404 Words | 8 Pages
  • Student Nurse Critical Review of Literature
    2172 words Research is the systematic and rigorous process of enquiry which aims to describe phenomena and to develop explanatory concepts and theories (Bowling 1997). A research question should be feasible, of interest to the researcher, original, relevant and ethically sound (Sim and Wright 2000). Evidence based health care involves the conscientious, explicit and judicious use of current best evidence about care of individual patients (Sackett et all 1996). In order to approach evidence...
    2,676 Words | 7 Pages
  • CDSCO - 1144 Words
    REGULATORY ENVIRONMENTS IN INDIA – CDSCO BY: SANJANA P RAO 4NM12BT029 DEPT OF BIOTECHNOLOGY, NMAMIT EVOLUTION OF INDIAN DRUG LEGISLATION • Drug is in the concurrent list of the Indian Constitution. • It is governed by both Central and State governments under the Drugs and Cosmetics Act, 1940 and Rules 1945 thereunder. • The Act was put forth with the objective of ensuring that the public are supplied with safety, efficacy and good quality of drugs. • It regulates the manufacture, sale,...
    1,144 Words | 7 Pages
  • Lifecycle Mgmt Pharmaceutical Bwp 070014
    Improving clinical development & manufacturing processes in pharmaceutical R&D organizations Product Lifecycle Management for the Pharmaceutical Industry An Oracle White Paper Author: Todd Hein, Oracle Life Sciences Key Contributors: i. ii. iii. Arvindh Balakrishnan, Oracle Life Sciences Hardeep Gulati, Oracle Product Strategy Michael Winkler, Oracle Life Sciences Oracle Pharmaceutical Solution Set Page 1 Improving clinical development & manufacturing processes in pharmaceutical R&D...
    2,598 Words | 11 Pages
  • Global Healthcare IT Outsourcing Industry worth $50.4 billion by 2018
    Global Healthcare IT Outsourcing Industry worth $50.4 billion by 2018 Outsourcing is an emerging phenomenon in the healthcare information technology market. It is a screening process wherein an organization selects the most efficient third-party service provider to effectively operate its management and administrative unit. Outsourcing of IT solutions in the healthcare industry has emerged as an efficient solution to mitigate rising healthcare costs and to meet the growing demand for quality...
    1,333 Words | 7 Pages
  • Biosimilar market in APAC - 1847 Words
     In APAC, the Biosimilar Market is Set to Grow The market sentiments towards biosimilars vary widely between the regulated and the semi- and unregulated markets. While regulated markets adopt an extremely cautious approach, the ‘pharmerging’ markets embrace the opportunity. Though ‘biobetters’ are often projected to have better future prospects over biosimilars, at least in the emerging markets the inclination is clearly towards biosimilars. The APAC region is particularly promising as a...
    1,847 Words | 6 Pages
  • Evidence based practice Task 2
    Evidence-Based Practice and Applied Nursing Research Types of Sources of Evidence: American Academy of Pediatrics and the American Academy of Family Physicians. [Clinical practice guideline:]. (2004). Source Of Evidence This evidence meets the criteria for a filtered source. It was sourced online from the Official Journal of the American Academy of Pediatrics and Family Physicians. Specialists from multi medical disciplines assembled to create an integrative systematic study and review of...
    2,466 Words | 7 Pages
  • Gsk Internal Analysis - 1632 Words
    Recent Strategy, "It's important that we generate more growth with less risk." GSK needs to find new sources of growth at a time when governments around the world are reforming healthcare and cutting spending. It is also outsourcing more research to partners to reduce risk. Its long-running collaboration with the US company, Theravance which is responsible for one of GSK's most promising new drugs, the asthma treatment Relovair, which is now in late-stage development. GSK recently upped its...
    1,632 Words | 5 Pages
  • psychology - 356 Words
    Abstract Successful clinical research outcomes are essential for improving patient care. Achieving this goal, however, implies an effective informed consent process for potential research participants. This article traces the development of ethical and legal requirements of informed consent and examines the effectiveness of past and current practice. The authors propose the use of innovative monitoring methodologies to improve outcomes while safeguarding consent relationships and activities....
    356 Words | 2 Pages
  • Kjjk - 1835 Words
    Nucleon, Inc. Teaching Outline Nucleon is a young biotech firm that faces a decision about whether to vertically integrate into manufacturing. The decision has long-term implications for the future of the firm. Throughout its short history, the firm has focused solely on R&D. However, with CRP-1, its first pharmaceutical product, nearing human testing, it must decide whether or not to build a small-scale pilot plant. Issues around opportunism, capability, and flexibility all have to be...
    1,835 Words | 10 Pages
  • Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019
    Gene therapy involves use of DNA as a pharmaceutical agent to treat diseases. It is one of the most important developments in the field of medicine that has potential to treat various lethal diseases such as HIV, cancer and cystic fibrosis. In the long run, biotechnology and clinical trial industries will benefit from developments in gene therapy and provide potential treatment solutions for various incurable diseases. Browse Full Report with TOC:...
    394 Words | 2 Pages
  • Case Study2 Merck Company
    BUAD820 – Case 2 Merck Case Decision Tree and Analysis Presented By – Sridevi Chennuri Nuray Coban Subhashini Reddy Merck & Company :Evaluating a Drug Licensing Opportunity • Background - Merck & Company : •In 2000, it was a global research-driven pharmaceutical company that discovers, develop, manufactures and markets a broad range of human and animal health products, directly and through its joint ventures, and provides pharmaceutical benefit management services through Merck-Medco Managed...
    606 Words | 5 Pages
  • Strategic Analysis of Pharmaceutical Company
    NATIONAL UNIVERSITY OF COMPUTER & EMERGING SCIENCES, ISLAMABAD [pic] MANAGEMENT INFORMATION SYSTEM Final Project Date: 7 May 2012 Submitted to: SIR ALI NASIR Submitted by: Usman Pervez 09-0001 Imran Shafqat 09-0175 Faheem Alam 09-0211 Muhammad Awais Ashraf 09-0278 Section ‘C’ QUESTION NO. 1: Conduct a Strategic Analysis of Industry and Stakeholder Analysis for MIS under consideration. STRATEGIC ANALYSIS OF PHARMACEUTICAL...
    7,430 Words | 27 Pages
  • Latest Report: Electrical Geodesics, Inc. (EGI) - Product Pipeline Analysis, 2014 update Market
    Electrical Geodesics, Inc. (EGI) - Product Pipeline Analysis, 2014 Update Market Trend, Size, Share, Growth and Forecast : Industry Analysis, Overview, Research and Development - Market Research Reports.Biz Electrical Geodesics, Inc. (EGI) is a medical device company. The company This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands. The...
    599 Words | 3 Pages
  • Case Report: Glaxosmithkline Reorganizing Drug Discovery (a)
    This case describes the reorganization of drug discovery at GlaxoSmithKline (GSK) following the formation of GSK from the merger of Glaxo Wellcome and SmithKline Beecham. This reorganization placed nearly 2,000 research scientists into six centers of excellence in drug discovery (CEDD). Each CEDD focused on a small set of therapeutic areas and possessed decision rights over the progression of pharmaceutical compounds through the early stages of development. It addresses issues about the benefits...
    2,097 Words | 7 Pages
  • Merck Kl798 Case - 920 Words
    Executive Summary Merck & Company has been presented with an opportunity to invest $30 million for the purchasing rights of an obesity and high cholesterol lowering drug, KL-798 from Kappa Labs. Based on the expected probabilities of success through each product-development phase for this new drug, as well as the costs involved, the net present value of the project is -$1.16 million and is therefore recommended that Merck passes on the investment. Sensitivity analysis also show that...
    920 Words | 3 Pages
  • Kendle International Inc - 2076 Words
    Kendle International Inc Candace Kendle, the chairman and CEO of Kendle International Inc and her husband Christopher C. Bergen, the president and CFO privately hold Kendle, a Contract Research Organisation which was incorporated in Cincinnati, Ohio in 1981. The Company provides integrated clinical research and drug developmental services on a contract basis to the pharmaceutical and biopharmaceutical industries. The Company's services comprise Phase II, III and IV of clinical trials. The CRO...
    2,076 Words | 7 Pages
  • Medical Device Industry Overview
    INDUSTRY & MARKET SEGMENT OVERVIEW The Medical Device (“MD”) industry is one of the largest and most stable industries in healthcare with a global market exceeding $140B in revenue. The US represents approximately 60% of that revenue, or $85B in revenue, with historical growth rates unimpacted by recessions of ~ 8%*. While significant, only 4 % of US healthcare costs can be attributed to devices (source: King & Donahoe, “Estimates of Medical Spending in the US). The US market produces...
    3,167 Words | 9 Pages
  • Miss - 893 Words
    CURRICULUM VITAE OF TSHIMANGADZO DIANA TSHISHONGA 1. PERSONAL DETAILS Date of Birth : 26 December 1981 Identity Number : 8112260513085 Postal Address : 46 Micheal Angelo Bronberg Street Noordwyk Midrand 1687 Contact Number : 0827781321/0787761867 Email Address : casdana@yahoo.com Drivers License : Code 08 Nationality : South African Sex : Female Race : Black...
    893 Words | 7 Pages
  • Reasons For Outsourcing - 3573 Words
    Shailesh KD et al. / IJPPDR / 4(1), 2014, 15-19. e-ISSN: 2249-7625 Print ISSN: 2249-7633 International Journal of Pharmacy Practice & Drug Research www.ijppdr.com REASONS FOR OUTSOURCING IN PHARMACEUTICAL INDUSTRY Shailesh Kumar Develpalli*¹, Malathi Jojula2, Bucha Reddy Ponakunti3 ¹Sr. Manager in General Administration Ricon Pharma Private Limited India, Hyderabad, Andhra Pradesh, India. ²Department of Pharmacy Microbiology, Sri Shivani College of Pharmacy, Warangal, Andhra Pradesh, India....
    3,573 Words | 15 Pages

All Clinical trial Essays